New injection aims to tame dangerous blood fats
Disease control
Recruiting now
This study is testing a new drug called RBD5044 to see if it can safely lower high levels of triglycerides and cholesterol in adults with mixed dyslipidemia. About 120 participants will receive either the drug or a placebo injection and be monitored for nearly a year. Researchers…
Phase: PHASE2 • Sponsor: Ribocure Pharmaceuticals AB • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC